Life sciences news
-
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
Tuesday March 29th 2022
Read more
-
Jyseleca® approved in Japan for ulcerative colitis
Monday March 28th 2022
Read more
-
argenx announces positive topline Phase 3 data from ADAPT-SC study evaluating subcutaneous efgartigimod for generalized myasthenia gravis
Tuesday March 22nd 2022
Read more
-
Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain
Thursday March 10th 2022
Read more
-
miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study
Thursday February 17th 2022
Read more
-
UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results
Friday February 4th 2022
Read more
-
Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes
Tuesday January 25th 2022
Read more
-
Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women
Friday January 14th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Oxurion provides update on clinical pipeline progress
Friday January 7th 2022
Read more
-
VIB research at the basis of experimental gene therapy against dementia
Wednesday December 22nd 2021
Read more
-
UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis
Friday December 10th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
